Alembic Pharmaceuticals Limited is an Indian multinational pharmaceutical company. It is part of one of India's oldest industrial conglomerates, the Alembic Group. The company’s headquarters is located in Vadodara, Gujarat. It has a presence both in local and global markets, especially in the US.
The company specializes in the production and marketing of generic pharmaceuticals, active pharmaceutical ingredients (APIs), and intermediaries. APLLTD is especially known for its expertise in the macrolides segment of anti-infective drugs.
The company offers several products for different healthcare needs. They have sorted their products into different categories. These categories include India Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs). Alembic develops specialty medicines across several chronic and acute therapies. It offers some of the following products:
Azithral is a brand name for azithromycin. It is an antibiotic that is used to treat a range of bacterial infections. This medicine is used for the conditions of respiratory infections, skin infections, ear infections, and STDs. It stops the growth of bacteria and helps the body fight off the infection. Azithral is available in various forms, including tablets, capsules, and liquid suspension.
Alecephin refers to cefalexin (also spelled cephalexin). This is an antibiotic belonging to the class of cephalosporin. It's used to treat bacterial infections. This includes those affecting the skin, bone, respiratory tract, and urinary tract. Cefalexin disrupts the bacterial cell wall synthesis that causes the death of the bacteria.
Atecard is a medicine specifically prescribed for managing high blood pressure (hypertension) and angina (chest pain). It may also be used in preventing heart attacks, particularly in individuals at risk. This medicine comes from a class of drugs known as beta-blockers. They work by slowing down the heart rate and reducing the demand for oxygen by the heart. This ultimately decreases the blood pressure.
Along with the general medicines, the company also produces therapeutic products. These products are used in various therapeutic areas including:
Alembic Pharmaceuticals is one of the top pharmaceutical companies in India. Therefore, it faces competition from both domestic and international pharmaceutical firms. Here's an overview of its competitors in India and globally:
This is India's largest pharmaceutical company. It specializes in generic drugs and active pharmaceutical ingredients (APIs).
This is another leading pharmaceutical company. It also offers a wide range of pharmaceutical services. This includes over-the-counter drugs, generics, biosimilars, and APIs.
Lupin is known for its formulation development and broad generic drug portfolio. This company is a competitor in the cardiovascular, diabetology, asthma, anti-infective, and NSAID segments.
EMS is a Brazilian pharmaceutical company. The company provides an extensive range of generic drugs. It has a significant presence in the Latin American pharmaceutical market.
Teva is a global leader in generic medicines. It has a strong presence in specialty medicines particularly in CNS and respiratory areas.
Sandoz is a significant pharmaceutical company that specializes in biosimilars. It also offers a wide range of products across therapeutic areas.
Alembic Pharmaceuticals follows the Standard Operating Procedures (SOPs). These SOPs comply with international regulatory standards. These include SOPs set by the FDA and EMA.
The company implements strict quality control measures and regular audits. It trains its staff continuously to guarantee the finest of the products. The company uses advanced manufacturing technologies and practices. All aspects of production meet or exceed the industry's SOPs for pharmaceutical companies.
The company shows a positive trend in its financial performance. The company has experienced a compounded sales growth of 14% over ten years. The recent year-over-year profit growth of 179%. The return on equity has varied over the years. However, it has shown a decrease in the last year to 7%. In the stock market, Alembic Pharmaceuticals has maintained steady growth with a 100% increase in the last year.
Additionally, Alembic Pharmaceuticals share price indicates the current market trends and performance of the Indian pharmaceutical sector.
The company has received recognition for its contributions to the pharmaceutical sector. It has been listed among Forbes' 'India’s Super 50 Companies 2016'. It has also received the “Thomson Reuters Top 50 Indian Innovators Award” in 2015.
To conclude, Alembic Pharmaceuticals is an international pharmaceutical company. It offers important generic medicines as well as therapeutic products. It has competitors both in local and international markets. The company follows strict SOPs to maintain the quality of the medicines. Overall it generates a huge profit and adds to the economy of India.